Publications by authors named "E Slinger"

Claim this Profile
C
Combined ibrutinib and venetoclax treatment vs single agents in the TCL1 mouse model of chronic lymphocytic leukemia.
Arnon P Kater, Erik Slinger, Gaspard Cretenet, Anne W Martens, Sriram Balasubramanian

Blood Adv· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eomes broadens the scope of CD8 T-cell memory by inhibiting apoptosis in cells of low affinity.
Inga Kavazović, Hongya Han, Giulia Balzaretti, Erik Slinger, Niels A W Lemmermann

PLoS Biol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The human cytomegalovirus-encoded G protein-coupled receptor UL33 exhibits oncomodulatory properties.
Jeffrey R van Senten, Maarten P Bebelman, Tian Shu Fan, Raimond Heukers, Nick D Bergkamp, Erik Slinger

J Biol Chem· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD40 signaling instructs chronic lymphocytic leukemia cells to attract monocytes via the CCR2 axis.
Martijn H A van Attekum, Jaco A C van Bruggen, Erik Slinger, M Cristina Lebre, Emilie Reinen

Haematologica· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell lines generated from a chronic lymphocytic leukemia mouse model exhibit constitutive Btk and Akt signaling.
Simar Pal Singh, Saravanan Y Pillai, Marjolein J W de Bruijn, Ralph Stadhouders, Odilia B J Corneth, Erik Slinger

Oncotarget· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis